Saturday 17 October 2026 Export BSX’s income statement to Excel — free account

Boston Scientific Corporation

Boston Scientific Corporation’s revenue for fiscal 2025 (year ended December 2025) was $20.1 billion, up 19.9% from fiscal 2024. In the quarter to June 2026, revenue grew 7.53%, EPS grew 14.8%, free cash flow grew 13.3% and total debt rose 8.95%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

44.39 0.25 +0.57%

Follow BSX

Alert me

Market cap: $64.0B
P/E: 17.9×
Fwd P/E: 17.8×
Dividend yield: —
F-score: 7/9
Altman Z: 5.41
Beneish M: −2.49
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	51.66	48.65	26.15	17.21
P/S ratio Full definition →		7.48	7.03	4.52	2.99
P/FCF ratio Full definition →		37.83	38.59	26.81	17.31
P/Operating CF Full definition →		107.71	103.49	267.75	42.57
P/B ratio Full definition →		6.12	5.77	3.57	2.49
Price to Tangible BV Full definition →		0.00	0.00	183.42	0.00
EV/Sales Full definition →		8.01	7.50	4.98	3.56
EV/EBITDA Full definition →		31.16	29.97	19.65	13.46
EV/Operating CF Full definition →		33.50	33.22	23.67	16.52
EV/FCF Full definition →		40.53	41.18	29.57	20.64
Quick Ratio Full definition →		0.77	0.90	0.98	0.56
Current Ratio Full definition →		1.51	1.62	1.90	1.24
Net Debt/EBITDA Full definition →		7.43	7.97	6.60	7.88
Debt/Assets Full definition →		27.16%	26.19%	24.87%	27.92%
Debt/Equity Full definition →		0.49	0.47	0.42	0.50
Asset Turnover Full definition →		0.48	0.48	0.49	0.48
Operating CF/Net income Full definition →		1.78	2.03	0.26	1.63
Capex/Depreciation Full definition →		(0.53)	(0.96)	(0.50)	(0.55)
Interest Coverage Full definition →		12.03	9.16	12.21	12.27
Research and Development Expense of Revenue Full definition →		10.15%	10.77%	9.92%	10.18%
Selling, General and Administrative Expense of Revenue Full definition →		34.61%	34.80%	34.46%	33.35%
Intangible Assets out of Total Assets Full definition →		0.59	0.58	0.58	0.57
Share Based Compensation of Revenue Full definition →		1.56%	1.34%	1.60%	1.60%
Graham Net Nets Full definition →		(0.08)	(0.07)	(0.10)	(0.19)
Graham Number Full definition →		26.04	27.00	30.81	30.91
Earnings Yield Full definition →		1.94%	2.06%	3.82%	5.81%
Free Cash Flow Yield Full definition →		2.64%	2.59%	3.73%	5.78%
Revenue per Share Full definition →		3.42	3.57	3.50	3.70
Operating CF per Share Full definition →		0.91	0.92	0.23	1.00
Capex per Share Full definition →		(0.12)	(0.24)	(0.12)	(0.13)
Free Cash Flow per Share Full definition →		0.78	0.68	0.12	0.87
Cash per Share Full definition →		0.86	1.33	0.98	0.37
Shareholders Equity per Share Full definition →		15.95	16.53	17.58	17.12
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		15.95	16.53	17.58	17.12
Free Cash Flow Full definition →		1,162.00	1,013.00	171.00	1,279.00
Working Capital Full definition →		2,707.00	3,355.00	4,113.00	1,544.00
Capital Expenditures Full definition →		(181.00)	(351.00)	(177.00)	(195.00)
Net Current Asset Value Full definition →		(11,042.00)	(10,407.00)	(9,563.00)	(12,072.00)
EV/EBIT Full definition →		44.70	41.70	27.12	18.04
Capex to Sales Full definition →		0.04	0.07	0.03	0.04
Price to Operating Income Full definition →		41.72	39.08	24.59	15.13
Other line items
Average Receivables Full definition →		2,664.50	2,742.00	2,860.00	2,932.00
Average Payables Full definition →		954.50	1,052.00	1,072.50	1,096.50
Average Inventory Full definition →		2,837.00	2,876.50	2,992.00	3,048.00
Average Assets Full definition →		40,392.50	41,534.00	42,245.50	43,387.50
Average Common Equity Full definition →		22,293.50	23,237.00	24,274.50	23,912.50

Show all line items

Columns are period end dates

Stockrow Weekly